# FDA Inspection 1280024 - Paul Harmatz, M.D. - August 21, 2025

Source: https://www.keypedia.com/records/fda_inspections/paul-harmatz-md/a07930b3-e4fb-41d6-8274-4bc448bf9886
Source feed: FDA_Inspections

> FDA Inspection 1280024 for Paul Harmatz, M.D. on August 21, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1280024
- Company Name: Paul Harmatz, M.D.
- Inspection Date: 2025-08-21
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1280024 - 2025-08-21](https://www.keypedia.com/records/fda_inspections/paul-harmatz-md/6fa913ab-fa1e-47dc-80a1-2a4a8273acd0)
- [FDA Inspection 1131540 - 2020-11-05](https://www.keypedia.com/records/fda_inspections/paul-harmatz-md/0b3fd96c-1ef8-4653-85ad-467fa9830b45)
- [FDA Inspection 1131717 - 2020-10-16](https://www.keypedia.com/records/fda_inspections/paul-harmatz-md/765ac772-c060-4982-93f0-69d4c4697ba3)
- [FDA Inspection 1014482 - 2017-06-16](https://www.keypedia.com/records/fda_inspections/paul-harmatz-md/e5ba9ca4-8a82-49e6-b10f-e497c7f9f381)
- [FDA Inspection 849987 - 2013-10-02](https://www.keypedia.com/records/fda_inspections/paul-harmatz-md/78e94531-6e35-4dc4-9117-54234f582b4a)

Company: https://www.keypedia.com/companies/paul-harmatz-md/bcbc74e9-fa1d-4cbc-9de7-14e621beb38c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d